BioSig Technologies, Inc. STEX Pre-tax stock-based compensation cost
Pre-tax stock-based compensation cost at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s pre-tax stock-based compensation cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s pre-tax stock-based compensation cost?
- BioSig Technologies, Inc. (STEX) reported pre-tax stock-based compensation cost of $25.37M in Q1 2026.
- How has BioSig Technologies, Inc.'s pre-tax stock-based compensation cost changed year-over-year?
- BioSig Technologies, Inc.'s pre-tax stock-based compensation cost increased by 1123.2% year-over-year, from $2.07M to $25.37M.
- What is the long-term trend for BioSig Technologies, Inc.'s pre-tax stock-based compensation cost?
- Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s pre-tax stock-based compensation cost has grown at a 56.6% compound annual growth rate (CAGR), from $9.5M to $57.1M.